This is a non-core endpoint: only basic statistics are computed.
Beningn neoplasm: Meninges, unspecified
CD2_BENIGN_MENINGES_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D32
- Name in latin
- Neoplasma benignum meningum non specificatarum
Similar endpoints
↥List of similar endpoints to
Beningn neoplasm: Meninges, unspecified
based on the number of shared cases.
Similar with more cases:
- Beningn neoplasm: Meninges, unspecified
- Benign neoplasm of meninges
- Benign neoplasm of meninges
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 557 | 403 | 154 |
| Unadjusted period prevalence (%) | 0.12 | 0.14 | 0.07 |
| Median age at first event (years) | 63.12 | 61.55 | 67.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 513
- Matched controls
- 5130
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
+∞
323.0
510
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
234.1
268.6
258
22
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
181.4
208.2
207
19
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
202.9
156.6
156
11
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
261.4
152.0
149
8
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
22.0
134.3
208
154
H02AB02
ATC
dexamethasone; systemic
127.6
127.3
133
14
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
222.4
75.4
76
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
150.5
74.2
77
6
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
238.7
62.6
63
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
12.0
53.8
103
105
N03AX14
ATC
levetiracetam; systemic
29.8
51.9
70
27
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
21.1
43.6
65
35
AA1AD
NOMESCO Finland
CT of head and brain
4.1
43.2
221
801
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
32.9
42.8
56
19
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
33.7
32
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
124.9
33.1
35
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.2
32.8
95
182
115
Kela drug reimbursment
Breast cancer
+∞
32.6
31
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
344.0
32.2
32
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
11.4
31.9
61
60
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
31.7
31.2
41
14
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.9
29.9
143
462
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
158.9
29.0
30
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
16.9
28.2
45
29
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
296.8
28.0
28
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
15.2
27.7
46
33
XCK00
NOMESCO Finland
Perimetry
5.2
27.6
93
211
D32.03
ICD-10 Finland
Benign meningioma in ventricles
79.6
27.1
30
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
285.2
27.0
27
*
N03AB02
ATC
phenytoin; systemic
17.5
26.7
42
26
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
13.5
26.4
46
37
130
Kela drug reimbursment
Malignant tumour
+∞
26.3
25
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
26.3
25
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
26.3
25
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
26.3
25
*
N03AF02
ATC
oxcarbazepine; oral
10.7
25.6
50
51
WF002
NOMESCO Finland
Radical radiotherapy
61.3
25.3
29
5
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.2
24
*
D32.05
ICD-10 Finland
Cerebral meninges
262.2
24.9
25
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
22.7
166
716
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.3
22.4
133
494
N03AF01
ATC
carbamazepine; oral, rectal
5.3
21.8
69
145
AA1BD
NOMESCO Finland
Extensive CT of head and brain
14.8
21.6
36
26
HAB40
NOMESCO Finland
Wedge excision of mammary gland
52.4
21.3
25
5
ZXC95
NOMESCO Finland
Use of surgical navigator
17.5
21.2
33
20
R51.80
ICD-10 Finland
Headache
3.4
19.5
106
367
A04AA02
ATC
granisetron; systemic, transdermal
+∞
18.9
18
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
18.9
18
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
103.9
18.7
20
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
196.9
18.7
19
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
17.8
17
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
17.8
17
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
25.1
17.5
24
10
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
16.9
102
377
D32
ICD-10 Finland
Benign neoplasm of meninges
+∞
16.8
16
*
L02BG04
ATC
letrozole; oral
20.9
16.6
24
12
XX3DW
NOMESCO Finland
Time consuming IT work
5.7
16.2
47
89
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
49.2
16.1
19
*
N03AG01
ATC
valproic acid; systemic, rectal
4.5
16.1
58
140
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
+∞
15.7
15
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.9
15.7
44
80
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.3
15.6
42
72
ZX050
NOMESCO Finland
Stereotactic radiotherapy
164.8
15.6
16
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
11.8
14.9
27
24
XA800
NOMESCO Finland
Neuropsychological investigation
5.7
14.9
43
81
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
82.5
14.6
16
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
82.5
14.6
16
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
17.6
14.4
22
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
14.3
113
491
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.4
14.1
72
236
WX882
NOMESCO Finland
High dependency care
9.0
13.9
29
34
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
+∞
13.6
13
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
13.6
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
143.6
13.5
14
*
H53.4
ICD-10 Finland
Visual field defects
7.6
13.4
31
43
ZXC40
NOMESCO Finland
Use of ultrasound
26.6
13.4
18
7
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
23.2
13.0
18
8
G40.10
ICD-10 Finland
Simple partial seizures
23.2
13.0
18
8
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
71.7
12.6
14
*
H47.2
ICD-10 Finland
Optic atrophy
71.7
12.6
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
71.7
12.6
14
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
32.9
12.6
16
5
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
12.5
12
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
12.5
12
*
N75
ICPC
Benign neoplasm nervous system
133.1
12.5
13
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
12.2
67
229
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.9
12.1
39
84
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
66.5
11.7
13
*
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
+∞
11.5
11
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
11.5
11
*
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
+∞
11.5
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.5
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
122.6
11.5
12
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
122.6
11.5
12
*
HAC20
NOMESCO Finland
Total mastectomy
122.6
11.5
12
*
AAK00
NOMESCO Finland
Cranioplasty
122.6
11.5
12
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
25.7
11.2
15
6
JN4BD
NOMESCO Finland
Extensive body CT
4.2
10.5
39
98
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.4
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
N03AX18
ATC
lacosamide; systemic
33.3
10.4
13
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.3
10.4
13
*
R4110
NOMESCO Finland
Physiotherapy
2.1
10.3
140
786
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
11.6
10.1
18
16
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
9.9
97
466
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.5
9.8
79
344
JN4AD
NOMESCO Finland
Body CT examination
5.1
9.8
30
62
2152
FHL
Extraction, big brain
56.1
9.7
11
*
H53.2
ICD-10 Finland
Diplopia
5.4
9.7
28
54
WX110
NOMESCO Finland
Local anesthesy
1.8
9.6
318
2429
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.3
9.5
28
55
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
101.8
9.4
10
*
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
L02BA01
ATC
tamoxifen; oral
+∞
9.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.4
9
*
HA1AA
NOMESCO Finland
X-ray mammography
4.6
9.3
31
70
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
19.0
9.0
13
7
N02BE01
ATC
paracetamol; systemic, rectal
2.1
8.9
439
3790
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
8.8
63
258
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
8.8
81
379
183
Kela drug reimbursment
Lamotrigin and topiramate
14.3
8.7
14
10
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
50.9
8.7
10
*
WF099
NOMESCO Finland
Other radiotherapy
91.5
8.4
9
*
N76
ICPC
Neoplasm nervous system unspecified
91.5
8.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
8.4
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.4
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.4
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
11.0
8.3
15
14
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.1
8.2
46
159
WX402
NOMESCO Finland
General anaesthesia
2.4
8.2
72
329
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.9
215
1507
N05BA01
ATC
diazepam; systemic, rectal
2.2
7.9
82
405
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.0
7.8
14
13
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
7.8
127
755
A04AA01
ATC
ondansetron; systemic, rectal
4.4
7.6
26
61
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.0
7.6
29
76
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
81.2
7.4
8
*
G44.2
ICD-10 Finland
Tension-type headache
2.3
7.4
74
357
N05CF01
ATC
zopiclone; oral
1.7
7.3
179
1209
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
Z51.5
ICD-10 Finland
Palliative care
5.6
7.3
20
37
G50.0
ICD-10 Finland
Trigeminal neuralgia
5.8
7.1
19
34
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.0
174
1176
XKD00
NOMESCO Finland
Uroflowmetry
2.3
7.0
65
304
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.0
101
571
WZC30
NOMESCO Finland
Teaching
2.5
7.0
52
218
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
14.0
6.9
11
8
XCD10
NOMESCO Finland
Electrophysiological examination of eye
4.3
6.9
24
58
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.4
6.9
14
17
S18
ICPC
Laceration/cut
1.7
6.9
198
1399
H02AB09
ATC
hydrocortisone; systemic
5.4
6.8
19
36
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
22.8
6.7
9
*
N06AB04
ATC
citalopram; systemic
1.8
6.7
124
764
ZXA00
NOMESCO Finland
Right side
1.8
6.7
142
917
B01AB05
ATC
enoxaparin; parenteral
1.8
6.5
139
898
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
6.5
41
155
X76
ICPC
Malignant neoplasm breast female
70.7
6.4
7
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
70.7
6.4
7
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
70.7
6.4
7
*
UKC02
NOMESCO Finland
Cystoscopy
2.1
6.4
76
396
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
6.4
125
782
G91.0
ICD-10 Finland
Communicating hydrocephalus
14.5
6.4
10
7
A02BC02
ATC
pantoprazole; systemic
1.6
6.4
326
2658
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.1
6.3
16
27
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
+∞
6.3
6
*
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
N28
ICPC
Limited function/disability (N)
7.2
6.3
14
20
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
6.2
45
187
A02BA02
ATC
ranitidine; systemic
1.8
6.2
116
718
R53
ICD-10 Finland
Malaise and fatigue
1.8
6.2
114
702
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
4.1
6.1
22
56
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
46
24
20.80
59.47
1.5
2.3
—
—
—
0
0
334
2197
2.30
19.99
6.8
5.3
1.2
1.2
mmol/l
1.15
297
1868
171
890
2.33
17.46
2.3
2.0
—
—
—
0
0
358
2549
2.13
15.97
5.6
3.9
6.7
6.7
mmol/l
0.02
344
2355
105
477
2.48
14.28
5.3
5.9
1.2
1.6
mmol/l
0.59
77
372
271
1813
1.96
13.54
4.3
3.5
—
—
—
0
0
287
1977
1.93
12.96
6.2
4.8
1.2
1.2
mmol/l
2.87
269
1732
229
1464
1.96
12.91
2.7
2.1
172.2
224.9
u/l
0.44
221
1380
25
47
5.52
12.88
2.4
1.3
—
—
—
0
0
17
21
8.32
12.81
2.5
1.3
—
—
—
0
0
301
2119
1.91
12.60
5.8
3.6
10.8
11.2
umol/l
0.18
285
1978
86
394
2.40
11.36
2.5
1.9
373.1
366.7
nmol/l
0.09
80
355
36
103
3.67
11.05
1.9
1.1
10.9
60.9
e6/l
0.51
29
83
36
103
3.67
11.05
2.0
1.3
1153.3
260.2
e6/l
0.72
31
85
314
2302
1.83
10.98
9.3
6.4
4.1
4.2
e9/l
0.56
282
1996
112
583
2.15
10.89
2.8
2.6
0.8
0.8
mmol/l
0.05
101
530
36
124
3.03
8.28
1.6
1.3
1058.8
510.5
mg/l
1.54
36
116
41
156
2.76
7.90
1.7
1.7
—
—
—
0
0
39
149
2.74
7.46
1.6
1.6
—
—
—
0
0
247
1822
1.64
7.39
4.7
3.8
47.8
50.5
ng/l
0.04
191
1295
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
114
2.92
6.96
2.2
2.7
0.3
0.4
u/ml
0.09
17
73
113
684
1.82
6.91
1.9
1.7
—
—
—
0
0
394
3322
1.64
6.39
8.4
5.3
76.5
76.4
u/l
0.03
371
3044
191
1363
1.61
6.30
2.6
2.2
78.3
57.1
u/l
0.41
176
1246
17
44
3.95
6.03
5.4
3.5
1.1
1.3
%
0.12
11
34
9
6
15.21
5.92
5.6
1.0
41.1
17.9
u/ml
—
9
6
49
241
2.13
5.44
1.6
1.6
—
—
—
0
0
164
1170
1.57
5.26
3.4
2.9
0.4
0.5
e6/l
0.12
130
890
19
59
3.30
5.21
1.1
1.3
—
—
—
0
0
49
246
2.09
5.17
2.8
1.5
12.5
4.6
ug/l
0.50
41
194
51
261
2.05
5.12
3.7
2.8
4.0
4.5
pmol/l
3.47
46
227
236
1834
1.50
5.06
4.6
3.5
34.8
35.5
g/l
1.22
216
1682
204
1544
1.51
4.94
3.4
3.1
—
—
—
0
0
61
345
1.86
4.60
5.2
5.8
7.4
10.4
mmol/l
3.83
55
324
84
525
1.71
4.53
4.5
4.2
1.0
1.0
mmol/l
1.13
74
467
47
246
1.99
4.45
1.2
1.5
—
—
—
0
0
26
106
2.52
4.44
1.8
1.4
—
—
—
0
0
32
153
2.16
3.86
2.2
1.8
1.7
1.4
ug/l
0.13
27
135
188
1464
1.43
3.73
3.3
2.1
2.4
2.4
mmol/l
0.49
165
1207
69
435
1.67
3.61
2.4
2.5
4.5
7.2
ug/l
1.16
55
379
122
900
1.46
3.18
4.6
4.0
314.5
257.7
ng/l
0.08
92
715
94
660
1.51
3.13
2.9
2.7
2.3
4.0
e6/l
1.53
54
352
49
293
1.74
3.12
1.3
1.6
—
—
—
0
0
89
621
1.52
3.05
20.3
25.2
1.6
1.2
inr
1.18
16
81
12
40
3.04
2.99
2.0
2.2
—
—
—
0
0
64
417
1.60
2.96
2.7
2.2
5.2
6.4
umol/l
0.68
52
363
99
715
1.47
2.87
2.9
2.5
1.4
2.0
e6/l
0.48
58
407
5
6
8.39
2.75
1.2
1.2
—
—
—
0
0
378
3400
1.35
2.73
5.0
4.4
12.9
12.6
mm/h
0.11
355
3113
6
10
6.05
2.70
7.7
2.5
—
—
—
0
0
7
15
4.71
2.60
1.3
1.2
—
—
—
0
0
7
15
4.71
2.60
1.3
1.2
—
—
—
0
0
26
138
1.93
2.45
4.0
3.9
3.8
3.9
mmol/l
0.17
26
127
24
128
1.91
2.25
1.2
1.2
—
—
—
0
0
60
412
1.51
2.24
2.3
3.4
172.4
226.4
ng/l
0.44
52
379
69
488
1.47
2.24
1.9
1.7
—
—
—
0
0
61
422
1.50
2.21
3.5
3.0
—
—
—
0
0
29
166
1.79
2.19
3.9
3.6
1.0
1.4
mmol/l
2.50
29
161
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
24
3.37
2.18
1.1
1.2
—
—
—
0
0
60
415
1.50
2.17
5.3
2.9
2.3
2.0
mmol/l
0.26
47
326
226
1940
1.28
2.10
2.5
2.3
76.9
79.7
nmol/l
0.82
201
1695
231
1989
1.28
2.10
2.1
2.0
97.7
97.2
pmol/l
0.06
108
955
464
4369
1.37
2.07
21.1
12.8
22.8
21.2
mg/l
0.63
405
3386
50
337
1.53
2.05
3.1
2.5
1.2
1.2
mmol/l
0.79
50
281
18
90
2.03
2.02
1.8
1.4
93.7
62.5
pmol/l
0.58
18
90
68
490
1.44
2.02
1.8
1.7
—
—
—
0
0
8
27
2.99
1.94
1.3
1.1
—
—
—
0
0
388
3579
1.28
1.90
5.1
4.1
14.8
14.9
pmol/l
0.70
364
3237
273
2418
1.25
1.90
3.0
2.6
—
—
—
0
0
122
981
1.31
1.85
1.7
1.8
936.8
1197.2
nmol/l
2.88
91
722
6
17
3.56
1.84
1.2
1.1
—
—
—
0
0
8
29
2.78
1.79
1.4
1.1
—
—
—
0
0
302
2717
1.24
1.79
3.2
2.9
47.7
45.0
u/l
0.23
274
2508
154
1285
1.27
1.76
3.2
2.6
26.7
32.2
u/l
3.02
146
1224
9
36
2.52
1.74
1.3
1.3
—
—
—
0
0
177
1505
1.26
1.73
3.4
2.9
2026.0
1454.6
ng/l
0.57
152
1268
49
348
1.45
1.60
2.5
1.6
65.5
67.3
g/l
1.09
44
306
106
857
1.29
1.55
2.8
2.2
2.4
2.4
mmol/l
0.03
85
731
437
4134
1.26
1.49
18.7
11.6
77.4
76.3
ml/min/173m2
0.51
394
3305
35
236
1.52
1.48
3.7
2.6
0.1
0.2
e6/l
1.05
35
227
132
1103
1.26
1.48
2.4
2.2
2.9
3.1
mg/l
0.38
113
923
10
45
2.24
1.47
2.3
1.5
—
—
—
0
0
20
117
1.74
1.47
2.0
1.7
3.1
4.5
iu/l
—
9
41
9
39
2.33
1.43
1.3
1.2
—
—
—
0
0
36
247
1.49
1.41
2.0
3.7
2.6
2.1
mmol/l
0.29
26
186
38
264
1.47
1.41
2.1
3.8
5.2
5.2
kpa
0.09
33
247
11
53
2.10
1.39
2.2
1.4
—
—
—
0
0
13
67
1.96
1.39
2.1
1.3
—
—
—
0
0
208
1837
1.21
1.38
3.0
2.7
108.3
105.9
ug/l
0.08
187
1672
9
41
2.21
1.37
1.0
1.2
—
—
—
0
0
6
23
2.63
1.37
1.0
1.6
—
—
—
0
0
6
23
2.63
1.37
2.0
2.3
—
—
—
0
0
5
17
2.96
1.36
1.8
1.5
—
—
—
0
0
11
54
2.06
1.33
1.1
1.2
—
—
—
0
0
68
530
1.32
1.31
2.8
2.4
19.8
23.1
%
1.30
56
449
9
44
2.06
1.27
1.2
1.1
—
—
—
0
0
16
92
1.76
1.26
1.1
2.0
117.5
129.8
g/l
—
8
65
127
1076
1.23
1.26
1.7
1.7
455.8
20938659.8
pmol/l
1.06
110
874
114
956
1.24
1.24
2.2
1.6
1.2
1.2
mg/l
0.05
87
738
9
45
2.02
1.23
1.2
1.1
—
—
—
0
0
9
45
2.02
1.23
1.2
1.1
—
—
—
0
0
72
579
1.28
1.12
2.6
2.3
2.4
2.3
g/l
0.07
63
540
9
47
1.93
1.02
1.2
1.1
—
—
—
0
0
9
47
1.93
1.02
1.2
1.1
—
—
—
0
0
9
47
1.93
1.02
1.2
1.1
—
—
—
0
0
15
91
1.67
1.01
1.2
1.2
—
—
—
0
0
5
23
2.18
0.98
3.8
1.4
—
—
—
0
0
20
133
1.52
0.95
1.4
1.2
—
—
—
0
0
7
37
1.90
0.94
1.0
1.3
—
—
—
0
0
73
603
1.24
0.93
5.2
4.8
33.7
33.3
%
0.13
54
383
12
70
1.73
0.93
2.1
1.5
—
—
—
0
0
9
52
1.74
0.92
1.1
1.2
—
—
—
0
0
18
118
1.54
0.92
1.3
1.4
—
1.3
—
0
15
11
63
1.76
0.90
1.4
1.4
—
—
—
0
0
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
6
29
2.08
0.89
1.3
1.7
—
—
—
0
0
30
220
1.38
0.89
4.1
2.0
1.1
1.2
%
0.14
30
220
29
212
1.39
0.88
4.1
2.0
0.6
0.7
%
0.13
29
204
6
30
2.01
0.87
1.2
1.5
—
—
—
0
0
57
696
0.80
0.86
1.4
1.4
—
—
—
0
0
21
145
1.47
0.86
1.5
1.7
0.0
0.1
iu/ml
—
7
27
478
4649
1.20
0.77
24.5
15.4
4.0
4.0
mmol/l
1.04
471
4508
437
4223
1.16
0.74
6.3
5.0
1.8
2.2
mu/l
0.86
408
3826
19
133
1.44
0.74
1.4
1.2
—
—
—
0
0
5
25
2.01
0.73
2.6
2.6
425.8
1235.8
u/ml
—
5
25
7
39
1.80
0.72
1.3
1.2
—
—
—
0
0
23
168
1.38
0.72
3.4
2.3
—
—
—
0
0
12
76
1.59
0.72
2.1
1.5
—
—
—
0
0
12
76
1.59
0.72
3.3
2.3
109.3
105.6
mmol/l
3.76
12
76
12
76
1.59
0.72
3.3
2.3
4.2
4.1
mmol/l
0.40
12
76
476
4635
1.19
0.71
24.6
15.3
139.6
139.8
mmol/l
0.88
469
4502
76
652
1.19
0.70
2.7
2.2
12.3
13.5
umol/l
0.75
66
595
11
69
1.61
0.69
1.9
1.6
—
—
—
0
0
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
12
78
1.55
0.66
1.3
1.2
—
—
—
0
0
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
99
879
1.15
0.61
5.7
3.9
3.1
2.1
ug/l
1.48
80
781
23
175
1.33
0.59
1.6
1.4
7.9
7.7
g/l
0.30
16
127
23
175
1.33
0.59
1.6
1.4
—
—
—
0
0
23
175
1.33
0.59
1.6
1.4
3.3
3.9
g/l
1.59
16
122
10
64
1.57
0.59
1.3
1.3
—
—
—
0
0
10
64
1.57
0.59
1.8
1.4
—
—
—
0
0
35
283
1.25
0.58
1.1
1.4
—
45.7
—
0
12
126
1143
1.13
0.57
1.5
1.5
20.2
21.3
nmol/l
0.39
112
962
6
36
1.67
0.57
1.2
1.1
1.5
1.5
nmol/l
—
6
28
71
619
1.17
0.56
8.3
6.9
—
—
—
0
0
377
3897
0.90
0.54
22.1
14.1
38.1
39.4
%
1.26
243
2578
9
61
1.48
0.54
1.1
1.1
—
—
—
0
0
6
97
0.61
0.52
1.5
1.5
—
—
—
0
0
78
690
1.15
0.52
5.2
3.7
21.8
24.9
%
1.26
45
338
446
4563
0.89
0.51
5.4
5.3
2.7
2.7
mmol/l
0.04
415
4161
478
4687
1.14
0.48
24.1
14.8
76.5
76.1
umol/l
0.09
478
4687
7
47
1.50
0.47
1.9
3.7
—
—
—
0
0
7
47
1.50
0.47
1.1
1.1
—
—
—
0
0
10
68
1.48
0.47
1.2
1.1
—
—
—
0
0
42
358
1.19
0.45
3.6
2.1
71.7
63.7
ml/min/173m2
—
10
148
7
50
1.40
0.45
1.1
1.1
—
103.6
—
0
7
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
138
1482
0.91
0.42
2.9
3.0
7.1
6.9
mmol/l
0.18
116
1239
38
323
1.19
0.42
1.9
1.9
0.2
0.2
g/l
0.45
33
299
142
1521
0.91
0.41
3.7
3.9
4.4
6.2
mg/mmol
0.73
92
909
5
33
1.52
0.41
3.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
123
1141
1.10
0.39
2.8
2.3
331.8
8095.7
umol/l
5.35
105
975
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
53
469
1.14
0.37
3.7
2.6
0.8
0.8
ug/l
0.03
38
319
27
321
0.83
0.37
1.6
1.7
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
11
146
0.75
0.36
1.2
1.4
—
—
—
0
0
6
42
1.43
0.35
3.0
1.4
—
—
—
0
0
9
125
0.72
0.35
1.3
1.6
—
—
—
0
0
11
145
0.75
0.35
1.4
1.5
—
—
—
0
0
12
91
1.33
0.34
1.5
1.3
—
—
—
0
0
12
91
1.33
0.34
1.5
1.3
—
—
—
0
0
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
6
45
1.34
0.34
1.3
1.4
—
—
—
0
0
345
3540
0.93
0.32
26.0
15.4
13.8
13.7
%
0.54
340
3446
11
83
1.33
0.32
1.5
2.4
14.6
16.6
%
—
6
38
128
1203
1.08
0.32
5.2
4.1
0.0
0.0
estimate
0.00
47
377
24
202
1.20
0.31
1.5
1.3
—
—
—
0
0
7
53
1.32
0.31
1.4
1.1
—
—
—
0
0
232
2232
1.07
0.30
5.3
3.9
0.0
0.0
estimate
0.00
49
389
16
129
1.25
0.30
2.0
1.4
—
—
—
0
0
40
354
1.14
0.30
2.8
1.9
26.2
33.1
u/l
0.89
33
285
439
4461
0.92
0.29
5.2
4.8
5.9
6.0
mmol/l
0.33
405
4026
7
56
1.25
0.29
2.7
1.4
—
—
—
0
0
420
4273
0.93
0.28
4.3
4.2
1.3
1.3
mmol/l
0.08
387
3843
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
232
2244
1.06
0.25
8.0
5.3
0.0
0.0
estimate
0.00
48
383
9
75
1.20
0.25
1.1
1.3
0.5
0.6
nmol/l
—
9
69
182
1752
1.06
0.23
6.0
4.1
—
—
—
0
0
13
107
1.22
0.21
1.4
1.3
—
—
—
0
0
23
201
1.15
0.21
6.6
3.2
24.5
24.2
mmol/l
0.17
23
177
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
234
2276
1.05
0.20
5.4
3.9
0.0
0.0
estimate
0.80
46
377
437
4423
0.94
0.20
4.8
4.6
1.5
1.5
mmol/l
0.41
405
4023
6
50
1.20
0.19
1.3
1.4
—
—
—
0
0
441
4460
0.95
0.18
4.8
4.7
4.7
4.7
mmol/l
0.44
413
4074
423
4281
0.95
0.18
6.9
6.1
40.8
40.2
mmol/mol
0.53
391
3957
14
119
1.18
0.18
1.6
1.6
—
—
—
0
0
13
110
1.19
0.17
1.2
1.1
—
—
—
0
0
116
1207
0.95
0.17
1.6
1.7
1.3
1.3
mmol/l
0.16
104
1004
42
389
1.09
0.16
3.4
3.5
79.7
82.1
ng/l
0.06
37
341
84
801
1.06
0.15
1.4
1.3
4.9
14.4
u/ml
1.32
27
296
6
77
0.78
0.15
1.0
1.2
40.5
17.8
u/l
—
6
66
20
224
0.89
0.15
1.8
1.5
—
—
—
0
0
23
252
0.91
0.13
1.7
1.6
—
—
—
0
0
91
936
0.97
0.08
1.3
1.2
1.6
1.9
u/ml
0.11
19
249
14
127
1.11
0.08
2.2
3.6
—
—
—
0
0
21
198
1.06
0.05
1.0
1.0
—
—
—
0
0
60
616
0.97
0.05
1.8
1.5
—
—
—
0
0
11
120
0.91
0.05
2.5
2.3
10.3
81.8
ug/min
—
6
78
84
829
1.02
0.02
1.4
1.3
64.2
36.4
iu/ml
0.42
30
279
470
4711
0.99
0.02
13.2
9.1
26.0
24.3
u/l
0.57
455
4501
104
1046
0.99
0.00
5.5
4.3
1.0
1.0
kg/l
0.30
26
146
30
304
0.99
0.00
1.1
1.2
149.1
129.9
iu/ml
—
10
129
9
91
0.99
0.00
1.4
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
7
77
0.91
0.00
1.4
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
1.3
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MENINGES_NOS_EXALLC – Beningn neoplasm: Meninges, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).